<DOC>
	<DOCNO>NCT00805324</DOCNO>
	<brief_summary>The purpose study test effectiveness safety desloratadine ( Aerius ) syrup child hayfever without asthma . Patients take desloratadine syrup day 28 day . Once week , doctor measure patient 's hayfever symptom . The doctor also rat much relief patient get treatment record side effect .</brief_summary>
	<brief_title>Study Effectiveness Safety Desloratadine ( Aerius ) Syrup Children With Hayfever With Without Asthma ( P03472 )</brief_title>
	<detailed_description />
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Rhinitis</mesh_term>
	<mesh_term>Rhinitis , Allergic</mesh_term>
	<mesh_term>Rhinitis , Allergic , Seasonal</mesh_term>
	<mesh_term>Desloratadine</mesh_term>
	<criteria>Children must &gt; = 6 &lt; 12 year age either sex race . Children 's parent ( ) legal representative ( ) must demonstrate willingness participate study comply procedure sign informed consent Children must free clinically significant disease ( SAR ) would interfere study evaluation Children 's parent ( ) legal representative ( ) must understand able adhere dose visit schedule , agree report concomitant medication adverse event Investigator designee The diagnosis seasonal allergic rhinitis without intermittent asthma assess : Clinical history sneezing , rhinorrhea ( nasal discharge/running nose postnasal drip ) , nasal stuffiness/congestion nasal itch nonnasal symptom ( eye symptom ) itching , burning , tear redness , previous pollen season Ascertained skin prick positivity ( RAST positivity ) one following : grass , parietaria , birch , hazelnut ( skin test perform within last year ) Children must clinically symptomatic SAR Visit 1 ( day 1 ) : total ( nasal + non nasal ) symptom score must &gt; = 8 nasal congestion score &gt; = 2 , nonnasal symptom severity score must &gt; = 2 Asthma symptom ( wheeze , cough , difficulty breathing , chest tightness ) evaluate visit 1 ( day 1 ) grade child concomitant asthma Children observe designate washout period prohibit medication Children persistent asthma ( mild , moderate severe ) perennial allergic rhinitis ( PAR ) Children rhinitis medicamentosa Children upper respiratory tract sinus infection require antibiotic therapy within 14 day prior Visit 1 ( day 1 ) , child viral upper respiratory infection within 7 day prior Visit 1 ( day 1 ) Children nasal structural abnormality , include nasal polyp mark septal deviation , significantly interfere nasal airflow Children , opinion Investigator , dependent upon nasal , oral ocular decongestant , nasal topical antihistamine , nasal steroid Children history hypersensitivity desloratadine excipients Children current clinically significant metabolic , cardiovascular , hepatic , renal , immunologic , neurologic , hematologic , gastrointestinal , cerebrovascular respiratory disease , disorder , judgment Investigator , may interfere study evaluation affect subject safety A known lack response H1antihistamines</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>12 Years</maximum_age>
	<verification_date>April 2015</verification_date>
</DOC>